Podcast Episodes
Back to Search
Immune Tolerance and MS. How the RED4MS Study Could Change MS Treatment with Dr. Andreas Lutterotti
Season 1 Episode 88
Andreas Lutterotti explains the mode of action, the concept of the early clinical trial RED4MS, and what a success could mean for patients.
You can r…
1 year, 8 months ago
#087: Understanding and managing Neuromyelitis Optica (NMOSD). Latest Advances in treatment with Dr. Luis Alfonso Zarco
Season 1 Episode 87
Neuromyelitis Optica Spectrum Disorder (NMOSD) need to be diagnosed and treated fast with highly effective therapies for a good prognosis.
You can re…
1 year, 8 months ago
Navigating Menopause with MS – Key insights on symptom progression, aging, and personalized care (ECTRIMS Special)
Season 1 Episode 86
Find out how the menopause affects MS. What new research reveals about progression, symptom management, biological aging and quality of life.
You can…
1 year, 9 months ago
ECTRIMS Special on innovative MS rehabilitation for better quality of life
Season 1 Episode 85
New approaches to MS Rehabilitation: From Telerehab to Ocean Sailing and individualized trainings plans for improved wellness.
You can read the compl…
1 year, 9 months ago
Vascular dysfunction and Multiple Sclerosis. How Your vessels Could Shape Your MS Journey with Dr. Jonathan Pansieri
Season 1 Episode 84
Dr. Jonathan Pansieri explains how vascular dysfunction could worsen multiple sclerosis and become a target for future treatment approaches.
You can …
1 year, 9 months ago
ECTRIMS Special on De-escalation and discontinuation of therapies for MS – What does it mean and how can it work?
Season 1 Episode 83
When can we consider de-escalation or even discontinuation of a high-efficient immunotherapy for MS without risking a disease worsening?
You can read…
1 year, 9 months ago
Living with neuromyelitis optica (NMO) in Denmark with Leda Bresnov
Season 1 Episode 82
Leda Bresnov shares her diagnosis, coping strategies, and insights on living with neuromyelitis optica (NMO) in Denmark.
You can read all questions a…
1 year, 10 months ago
Navigating Treatment and Support for MS, NMOSD, and MOGAD in Montenegro with Dr. Sanja Gluscevic
Season 1 Episode 81
Dr. Sanja V. Gluscevic, a neurologist from Montenegro, specializes in MS, NMOSD and MOGAD, and is dedicated to patient care and advocacy.
You can rea…
1 year, 10 months ago
B-Cell Depletion – Ocrelizumab (Ocrevus), Ofatumumab (Kesimpta, Bonspri), Rituximab (Mabthera, Rituxan), Ublituximab (Briumvi) for active RRMS and SPMS, and early PPMS
Season 1 Episode 80
Learn more about b-cell depletion, including Ocrevus, Kesimpta, Bonspri, Mabthera, Rituxan, and Briumvi, used for active RRMS, SPMS, and PPMS.
You ca…
1 year, 10 months ago
Special: ECTRIMS 2024 - Personalized MS treatments, genetic risk factors and the benefits of early, effective therapies for women and children
Season 1
Personalized treatments, genetic risk factors, gender differences and the advantages of early, highly effective therapies.
You can read the full arti…
1 year, 10 months ago